Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director MAYLEBEN TIMOTHY M
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Girao Tiago
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Callori Fred
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Batycky Alka
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Adsett Roger
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Garabedian Christopher Nishan
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Cataldi Fabio
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Oakes Gregory
Landos Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(47.7%),Joseph Edelman(47.7%), etc.
Landos Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Xontogeny, LLC(9.9%)
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Cataldi Fabio
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Oakes Gregory
Landos Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Josep Bassaganya-Riera(0%)
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Batycky Alka
Landos Biopharma | 3: Initial statement of beneficial ownership of securities-Director Batycky Alka
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director MAYLEBEN TIMOTHY M
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Girao Tiago
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Garabedian Christopher Nishan
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Callori Fred
Landos Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Adsett Roger
No Data